Proactive Investors - Run By Investors For Investors

Investor Update: Endorsement for Angle's liquid biopsy system Parsortix

Top stories from the Proactive Investors UK newsroom.

Angle (LON:AGL) has received an endorsement for its liquid biopsy system Parsortix from European cancer centre UKE, which says it has potential as a biomarker to test for lung cancer.

Security group Westminster (LON:WSG) has signed a collaboration agreement with Hazar International that will see the two work together on projects in Saudi Arabia.

Bushveld Minerals (LON:BMN) has published a maiden mineral resource estimate for the Brits vanadium Project in South Africa.

FairFX Group (LON:FFX) has received approval from the FCA to offer loan products to business and retail customers.

Shares in San Francisco-based workplace messaging service Slack soared in first dealings on the New York Stock Exchange last night.  The price jumped 60% to US$41 per share.

UK transport booking app Trainline is aiming for a £1.7bn valuation in its upcoming London flotation. The company priced its initial public offering at 350p per share – the top end of its targeted range.

 
Meet Yellow Cake PLC, Avation PLC, Manolete Partners PLC and Crossword Cybersecurity Plc at our event, London , 05 September 2019. Register here »
View full PROAC profile View Profile

Proactiveinvestors Timeline

© Proactive Investors 2019

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use